Hi there,

Democracy Now! is celebrating 28 years on the air. Since our very first broadcast in 1996, Democracy Now! has been committed to bringing you the stories, voices and perspectives you won't hear anywhere else. In these times of war, climate chaos and elections, our reporting has never been more important. Can you donate $10 to keep us going strong? Today a generous donor will DOUBLE your donation, making it twice as valuable. Democracy Now! doesn't accept advertising income, corporate underwriting or government funding. That means we rely on you to make our work possible—and every dollar counts. Please make your gift now. Thank you so much.
-Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.


Denmark, Norway and Iceland Halt AstraZeneca Vaccinations over Blood Clot Fears

HeadlineMar 12, 2021

The U.S. recorded 62,000 new coronavirus infections and over 1,500 deaths Thursday as governors continue to roll back public health measures.

In Europe, Demark, Norway and Iceland have suspended use of AstraZeneca’s COVID-19 vaccine after reports of severe cases of blood clots — and one death — in vaccinated people. It’s not known if the vaccine caused the clots, and European Union regulators say the vaccine’s benefits continue to outweigh its risks.

Meanwhile, Reuters is reporting that Biden administration officials have denied requests to ship millions of stockpiled doses of AstraZeneca vaccine from Ohio and Maryland to countries desperate to use them — even though the vaccine is not approved for use in the United States.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation